10,226 Shares in InfuSystem Holdings, Inc. (NYSE:INFU) Bought by Summit Global Investments

Summit Global Investments bought a new position in shares of InfuSystem Holdings, Inc. (NYSE:INFU) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,226 shares of the company’s stock, valued at approximately $86,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in INFU. First Eagle Investment Management LLC grew its holdings in shares of InfuSystem by 25.9% during the 4th quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company’s stock valued at $7,676,000 after purchasing an additional 186,668 shares during the last quarter. Barclays PLC grew its stake in shares of InfuSystem by 300.5% during the third quarter. Barclays PLC now owns 28,597 shares of the company’s stock worth $192,000 after buying an additional 21,457 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of InfuSystem during the third quarter worth $87,000. Bank of New York Mellon Corp lifted its stake in shares of InfuSystem by 14.3% in the 4th quarter. Bank of New York Mellon Corp now owns 91,219 shares of the company’s stock valued at $771,000 after acquiring an additional 11,436 shares during the last quarter. Finally, Legato Capital Management LLC bought a new position in shares of InfuSystem in the 4th quarter valued at $85,000. Institutional investors own 71.13% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on INFU. StockNews.com upgraded InfuSystem from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 14th. Sidoti raised InfuSystem to a “strong-buy” rating in a research note on Tuesday, March 18th.

InfuSystem Price Performance

Shares of NYSE:INFU opened at $6.15 on Wednesday. The firm has a market cap of $129.21 million, a PE ratio of 102.52 and a beta of 1.75. InfuSystem Holdings, Inc. has a 52 week low of $5.29 and a 52 week high of $9.97. The firm’s fifty day moving average is $7.36 and its 200-day moving average is $7.55. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.